This may be due to the fact that tumor cells have a stock of integrin β1 mRNA and use it under unfavorable conditions to increase integrin β1 expression at the protein level, compensating for the stress of blocking fibronectin ligands in the ECM and integrin β1 itself, thereby increasing cell–ECM interaction and reducing migration. This evidence concerns the gene FN1 and neoplasm.